Calimmune

CSL snags a preclinical stem cell therapy in $416M Calimmune buyout
Endpoints
Mon, 08/28/17 - 09:29 am
CSL
Calimmune
M&A
stem cells
HIV biotech Calimmune bags $15M to move one-time gene therapy into the clinic
Fierce Biotech
Wed, 05/27/15 - 09:59 am
HIV
gene therapy
Calimmune